LAGEVRIO
- Business
Merck gains over $3.2B in sales from coronavirus pill in Q1
Pharmaceutical firm estimates $5 to $5.5B from COVID-19 pill this year US pharmaceutical firm Merck gained more than $3.2 billion…
Read More »
Pharmaceutical firm estimates $5 to $5.5B from COVID-19 pill this year US pharmaceutical firm Merck gained more than $3.2 billion…
Read More »